17 November 2014 | Company results | By BioSpectrum Bureau
China Pharma Q3 2014 revenue dips by 31%
The loss of $2.3 million is incurred due to a natural disaster, the company states
Singapore: China Pharma Holdings' third quarter revenue has slided down by over 31 percent touching $5.5 million from $8.1 million in the previous year.
According to the company, the loss of $2.3 million is incurred due to a natural disaster during the period. The operating loss for the three months ended September 30, 2014 was $6 million, compared to operating loss of $2.7 million in the same period in 2013.
The company has stated that due to a typhoon in July 2014, the manufacturing facilities suffered considerable damage along with suspension of water and electricity supply for several days.